Pulmonary hypertension in hereditary haemorrhagic teleangiectasia;Pulmonalvaskuläre Beteiligung bei Morbus Osler 1

Pneumologie

Volumn 63, Issue 11, 2009, Pages 669-674

  Reichenberger, F ^a   Wehner, L E ^b   Breithecker, A ^a   Voswinckel, R ^a   Mensch, O ^a   Schulz, R ^a   Ghofrani, H A ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; BOSENTAN; ECHOVIST; ENDOGLIN; LOW MOLECULAR WEIGHT HEPARIN; SILDENAFIL;

ADULT; AGED; ARTERIOVENOUS MALFORMATION; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; EPISTAXIS; FEMALE; GENE MUTATION; HUMAN; LUNG CIRCULATION; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RENDU OSLER WEBER DISEASE; THROMBOEMBOLISM;

ACTIVIN RECEPTORS, TYPE II; ADULT; AGED; ANTIGENS, CD; FEMALE; HETEROZYGOTE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; YOUNG ADULT;

EID: 70449389489     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0029-1215111     Document Type: Article

References (14)

1. Shovlin C L., Letarte M. Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999 54 714-729
2. Olschewski H, Hoeper M M., Borst M M., et al. Diagnose und Therapie der chronischen pulmonalen Hypertonie. Pneumologie 2006 60 749-771
3. Cottin V, Dupuis-Girod S, Lesca G, et al. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease). Respiration 2007 74 361-378 (Pubitemid 47093147)
4. Lerut J, Orlando G, Adam R, et al. European Liver Transplant Association. Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry. Ann Surg 2006 244 854-862
5. Wehner L E., Folz B J., Argyriou L, et al. Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations. Clin Genet 2006 69 239-245
6. Cottin V, Plauchu H, Bayle J Y., et al. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 2004 169 994-1000
7. Olivieri C, Lanzarini L, Pagella F, et al. Echocardiographic screening discloses increased values of pulmonary artery systolic pressure in 9 of 68 unselected patients affected with hereditary hemorrhagic telangiectasia. Genet Med 2006 8 183-190
8. Chavan A, Caselitz M, Gratz K F., et al. Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations. Eur Radiol 2004 14 2079-2085
9. Hoeper M M., Halank M, Marx C, et al. Bosentan therapy for portopulmonary hypertension. Eur Respir J 2005 25 502-508
10. Reichenberger F, Voswinckel R, Steveling E, et al. Sildenafil treatment for portopulmonary hypertension. Eur Respir J 2006 28 563-567
11. Hughes R J., Jais X, Bonderman D, et al. The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study. Eur Respir J 2006 28 138-143 (Pubitemid 44914271)
12. Reichenberger F, Voswinckel R, Enke B, et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J 2007 30 922-927
13. Mayer E, Klepetko W. Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006 3 589-593 (Pubitemid 44411625)
14. Lesca G, Olivieri C, Burnichon N, et al. French-Italian-Rendu-Osler Network. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med 2007 9 14-22